Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Interest & Investment Income (2023 - 2026)

Phibro Animal Health has reported Interest & Investment Income over the past 8 years, most recently at -$11.8 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 30.68% year-over-year to -$11.8 million; the TTM value through Dec 2025 reached -$41.8 million, down 143.12%, while the annual FY2025 figure was -$34.6 million, 86.67% down from the prior year.
  • Interest & Investment Income for Q4 2025 was -$11.8 million at Phibro Animal Health, up from -$12.1 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.1 million in Q3 2024 and troughed at -$12.1 million in Q3 2025.
  • A 3-year average of -$6.2 million and a median of -$6.7 million in 2024 define the central range for Interest & Investment Income.
  • Biggest five-year swings in Interest & Investment Income: surged 124.63% in 2024 and later crashed 1172.86% in 2025.
  • Year by year, Interest & Investment Income stood at $1.1 million in 2023, then plummeted by 945.49% to -$9.0 million in 2024, then plummeted by 30.68% to -$11.8 million in 2025.
  • Business Quant data shows Interest & Investment Income for PAHC at -$11.8 million in Q4 2025, -$12.1 million in Q3 2025, and -$8.6 million in Q2 2025.